Ascorbate availability and neurodegeneration in amyotrophic lateral sclerosis

Medical Hypotheses

Volumn 48, Issue 4, 1997, Pages 281-296

  Kok, A B ^a  

^a SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BINDING COMPETITION; CALCIUM HOMEOSTASIS; CLINICAL FEATURE; DRUG BIOAVAILABILITY; DRUG RECEPTOR BINDING; ENZYME BINDING; ENZYME REGULATION; GUINEA PIG; HUMAN; NERVE DEGENERATION; NONHUMAN; ONSET AGE; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR AFFINITY;

CAVIA PORCELLUS; SUS SCROFA;

EID: 0030968714     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(97)90097-9     Document Type: Article

References (171)

1. Rowland L P. Amyotrophic lateral sclerosis: human challenge for neuroscience. Proc Natl Acad Sci 1995; 92: 1251-1253.
2. Collard J-F, Côté F, Jullien J-P. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature 1995; 375: 61-64.
3. Jones C T, Swingler R J, Simpson S A, Brock D J. Superoxide dismutase mutations in an unselected cohort of Scottish amyotrophic lateral sclerosis patients. J Med Genet 1995; 32: 290-292.
4. Bowling A C, Schulz J B, Brown RH Jr, Beal M F. Superoxide dismutase activity, oxidative damage, and mitochondrial metabolism in familial and sporadic amyotropic lateral sclerosis. J Neurochem 1993; 61: 2322-2325.
5. Smith R G, Hamilton S, Hofmann F et al. Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis. N Engl J Med 1992; 327: 1721-1728.
6. Grünewald R A. Ascorbic acid in the brain. Brain Res Rev 1993; 18: 123-133.
7. Stamford J A, Kruk Z L, Miller J. Regional differences in extracellular ascorbic acid levels in the rat brain determined by high speed cyclic voltammetry. Brain Research 1984; 229: 289-295.
8. Schenk J O, Miller E, Gaddis R, Adams R N. Homeostatic control of ascorbate concentration in CNS extracellular fluid. Brain Research 1982; 253: 353-356.
9. Rice M E. Preferential localization of ascorbate in neurons and glutathione in glia. Submitted for publication.
10. Rice M E, Lee E J K, Choy Y. High levels of ascorbic acid, not glutathione, in the CNS of anoxia-tolerant reptiles contrasted with levels in anoxia-tolerant species. J Neurochem 1995; 64: 1790-1799.
11. Rice M E, Russo-Menna I. Ascorbate in neurons and GSH in glia: evidence from developing cortex, hippocampus, and cerebellum. Soc Neurosci Abstr 1995; 21: 1513.
12. Murakami K, Muto N, Fukazawa K, Yamamoto I. Comparison of ascorbic acid and ascorbic acid 2-O-alphaglucoside on the cytotoxicity and bioavailability to low density cultures of fibroblasts. Biochem Pharmacol 1992; 44: 2191-2197.
13. Hisanaga K, Sagar S M, Sharp F R. Ascorbate neurotoxicity in cortical cell culture. Ann Neurol 1992; 31: 562-565.
14. Morse N R, Tebbey P W, Sandstrom P A, Buttke T M. Induction of apoptosis in lymphoid cells by thiol-mediated oxidative stress. Protoplasma 1995; 184: 181-187.
15. Sandstrom P A, Mannie M D, Buttke T M. Inhibition of activation-induced death in T cell hybridomas by thiol antioxidants: oxidative stress as a mediator of apoptosis. J Leukocyte Biol 1994; 55: 221-226.
16. Buttke T M, Sandstrom P A. Redox regulation of programmed cell death in lymphocytes. Free Radical Research 1995; 22: 389-397.
17. Moser U. Uptake of ascorbic acid by leukocytes. Ann NY Acad Sci 1987; 498: 200-215.
18. Deng H-X, Hentati A, Tainer J A et al. Amyotrophic lateral sclerosis and structural defects in Cu/Zn superoxide dismutase. Science 1993; 261: 1047.
19. Gurney M E, Pu H, Chiu A Y et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 1994; 264: 1772-1775.
20. Ripps M E, Huntley G W, Hof P R, Morrison J H, Gordon J W. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophioc lateral sclerosis. Proc Natl Acad Sci 1995; 92: 689-693.
21. Dal Canto M C, Gurney M E. Neuropathological changes in two lines of mice carrying a transgenic gene for mutant human Cu, Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS). Brain Research 1995; 676: 25-10.
22. Halliwell B. How to characterize a biological antioxidant. Free Rad Res Commun 1990; 9: 1-32.
23. Takagi K, Kanemitsu H, Tomukai N et al. Changes of superoxide dismutase activity and ascorbic acid in focal cerebral ischaemia in rats. Neurol Res 1992; 14: 26-30.
24. Rice M E, Perez-Pinzon M A, Lee E J. Ascorbic acid, but not glutathione, is taken up by brain slices and preserves cell morphology. J Neurophysiol 1994; 71: 1591-1596.
25. Sciamanna M A, Lee C P. Ischemia/reperfusion-induced injury of forebrain mitochondria and protection by ascorbate. Arch Biochem Biophys 1993; 305: 215-224.
26. Ranjan A, Theodore D, Haran R P, Chandy M J. Ascorbic acid and focal ischaemia in a primate model. Acta Neurochirurgica 1993; 123: 87-91.
27. Zeng L H, Wu J, Carey D, Wu T W. Trolox and ascorbate: are they synergistic in protecting liver cells in vitro and in vivo? Biochem Cell Biol 1991; 69: 198-201.
28. Paller M S, Eaton J W. Hazards of antioxidant combinations containing superoxide dismutase. Free Rad Biol Med 1995; 18: 883-889.
29. Carri M T, Battistoni A, Polizio F, Desideri A, Rotilio G. Impaired copper binding by the H46R mutant of human Cu, Zn superoxide dismutase, involved in amyotrophic lateral sclerosis. FEBS Lett 1994; 356: 314-316.
30. Figlewicz D A, Krizus A, Martinoli M G et al. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum Molec Genet 1994; 3: 1757-1761.
31. Cote F, Collard J F, Julien J P. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis. Cell 1993; 73: 35-46.
32. Stadtman E R. Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. Annu Rev Biochem 1993; 62: 797-821.
33. Steinert P M, North A C, Parry D A. Structural features of keratin intermediate filaments. J Invest Dermatol 1994; 103 (5 Suppl): 19S-24S.
34. Steinert P M, Marekov L N, Fraser R D, Parry D A. Keratin intermediate filament structure. Crosslinking studies yield quantitative information on molecular dimensions and mechanism of assembly. J Molec Biol 1993; 230: 436-452.
35. Montine T J, Farris D B, Graham D G. Covalent crosslinking of neurofilament proteins by oxidized catechols as a potential mechanism of Lewy body formation. J Neuropathol Exper Neurol 1995; 54: 311-319.
36. Dean R T, Wolff S P, McElligott M A. Histidine and proline are important sites of free radical damage to proteins. Free Rad Res Commun 1989; 7: 97-103.
37. Monboisse J C, Borel J P. Oxidative damage to collagen. Free Rad Ag (EXS) 1992; 62: 323-327.
38. Zemlan F P, Thienhaus O J, Bosmann H B. Superoxide dismutase activity in Alzheimer's disease: possible mechanism for paired helical filament formation. Brain Research 1989; 476: 160-162.
39. Vogelsang G D, Zemlan F P, Dean G E. Hyperpurification of paired helical filaments reveals elevations in hydroxyproline content and a core structure related peptide fragment. Progr Clin Biol Res 1989; 317: 791-800.
40. Hóllosi M, Ürge L, Perczel A et al. Metal ion-induced conformational changes of phosphorylated fragments of human neurofilament (NF-M) protein. J Molec Biol 1992; 223: 673-682.
41. Beitner R. Control of glycolytic enzymes through binding to cell structures and by glucose-1,6-bisphosphate under different conditions. The role of Ca2+ and calmodulin. Int J Biochem 1993; 25: 297-305.
42. Rebec G V, Pierce R C. A vitamin as neuromodulator: ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission. Progr Neurobiol 1994; 43: 537-565.
43. O'Neill R D, Fillenz M. Circadian changes in extracellular ascorbate in rat cortex, accumbens, striatum, and hippocampus: correlations with motor activity. Neurosci Lett 1985; 60: 331-336.
44. Kalcheim C, Bacher E, Dulcsin D, Vogel Z. Ciliary ganglia and spinal cord explants release an ascorbate-like compound which stimulates proline hydroxylation and collagen formation in muscle cultures. Neurosci Lett 1985; 58: 219-224.
45. Buettner G R. The pecking order of free radicals and antioxidants: lipid peroxidation, α-tocopherol, and ascorbate. Arch Biochem Biophys 1993; 300: 535-543.
46. Sharma M K, Buettner G R. Interaction of vitamin C and vitamin E during free radical stress in plasma: and ESR study. Free Rad Biol Med 1993; 14: 649-653.
47. Meister A. Glutathione, ascorbate, and cellular protection. Cancer Research 1994; 54: 1969s-1975s.
48. Jain A, Mårtensson J, Mehta T, Krauss A N, Auld P A M, Meister A. Ascorbic acid prevents oxidative stress in glutathione-deficient mice: effects on lung type 2 cell lamellar bodies, lung surfactant and skeletal muscle. Proc Natl Acad Sci 1992; 89: 5093-5097.
49. Bartlett D, Church D F, Bounds P, Koppenol W H. The kinetics of the oxidation of L-ascorbic acid by peroxynitrite. Free Rad Biol Med 1995; 18: 85-92.
50. Dhanbhoora C M, Babson J R. Thiol depletion induces lethal cell injury in cultured cardiomyocytes. Arch Biochem Biophys 1992; 293: 130-139.
51. Fernandes R S, Cotter T G. Apoptosis or necrosis: intracellular levels of glutathione influence mode of cell death. Biochem Pharmacol 1994; 48: 675-685.
52. Tu B, Walling A, Moldeus P, Cotgreave I. The cytoprotective roles of ascorbate and glutathione against nitrogen dioxide toxicity in human endothelial cells. Toxicology 1995; 98: 125-136.
53. Hillered L, Nilsson P, Ungerstedt U, Ponten U. Trauma-induced increase of extracellular ascorbate in rat cerebral cortex. Neurosci Lett 1990; 113: 328-332.
54. Hillered L, Persson L, Bolander H G, Hallstrom A, Ungerstedt U. Increased extracellular levels of ascorbate in the striatum after middle cerebral artery occlusion in the rat monitored by intracerebral microdialysis. Neurosci Lett 1988; 95: 286-290.
55. Kihara T, Sakata S, Ikeda M. Direct detection of ascorbyl radical in experimental brain injury: microdialysis and an electron spin resonance spectroscopic study. J Neurochem 1995; 65: 282-286.
56. Feuerstein T J, Weinheimer G, Lang G, Ginap T, Rossner R. Inhibition by ascorbic acid of NMDA-evoked acetylcholine release in rabbit caudate nucleus. Naunyn Schmiedeberg's Arch Pharmacol 1993; 348: 549-551.
57. Majewska M D, Bell J A. Ascorbic acid protects neurons from injury induced by glutamate and NMDA. Neuroreport 1990; 1: 194-196.
58. Majewska M D, Bell J A, London E D. Regulation of the NMDA receptor by redox phenomena: inhibitory role of ascorbate. Brain Research 1990; 537: 328-332.
59. Pazdernik T L, Romanas M M, Nelson S R, Samsom F E. The effectiveness of ascorbate and urate as antioxidants at concentrations in brain and extracellular fluid. FASEB J 1994; 8: 3912.
60. Duncan M W. Role of the cycad neurotoxin BMAA in the amyotrophic lateral sclerosis-parkinsonism dementia complex of the western pacific. Adv Neurol 1991; 56: 301-310.
61. Beckman J S, Carson M, Smith C D, Koppenol W H. ALS, SOD and peroxynitrite [letter]. Nature 1993; 364: 584.
62. Tsai G E, Gastfriend D R. Nitric oxide-induced motor neuron disease in a patient with alcoholism. N Engl J Med 1995; 332: 1036.
63. Beckman J S, Chen J, Crow J P, Ye Y Z. Reactions of nitric oxide, superoxide and peroxyntitrite with superoxide dismutase in neurodegeneration. Progr Brain Res 1994; 103: 371-380.
64. Virgo L, de Belleroche J. Induction of the immediate early gene c-jun in human spinal cord in amyotrophic lateral sclerosis with concommitant loss of NMDA receptor NR-1 and glycine transporter mRNA. Brain Research 1995; 676: 196-204.
65. Kalb R G, Agostini J. Molecular evidence for nitric oxide-mediated motor neuron development. Neurosci Lett 1993; 57: 1-8.
66. Miele M, Boutelle M G, Fillenz M. The physiologically induced release of ascorbate in rat brain is dependent on impulse traffic, calcium influx and glutamate uptake. Neuroscience 1994; 62: 87-91.
67. Cammack J, Ghasemzadeh B, Adams R N. Electrochemical monitoring of brain ascorbic acid changes associated with hypoxia, spreading depression, and seizure activity. Neurochem Res 1992; 17: 23-27.
68. Sharma S C, Wilson C W. The cellular interaction of ascorbic acid with histamine, cyclic nucleotides and prostaglandins in the immediate hypersensitivity reaction. Int J Vit Nutr Res 1980; 50: 163-170.
69. Fann Y D, Rothberg K G, Tremml P G, Douglas J S, DuBois A B. Ascorbic acid promotes prostanoid release in human lung parenchyma. Prostaglandins 1986; 31: 361-368.
70. Brick P L, Howlett A C, Beinfeld M C. Synthesis and release of vasoactive intestinal polypeptide (VIP) by mouse neuroblastoma cells: modulation by cyclic nucleotides and ascorbic acid. Peptides 1985; 6: 1075-1078.
71. Huang W, Yang Z, Lee D, Copolov D L, Lim A T. Ascorbic acid enhances forskolin-induced cyclic AMP production and proANF mRNA expression of hypothalamic neurons in culture. Endocrinology 1993; 132: 2271-2273.
72. Manaker S, Caine S B, Winokur A. Alterations in receptors for thyrotropin-releasing hormone, serotonin, and acetylcholine in amyotrophic lateral sclerosis. Neurology 1988; 38: 1464-1474.
73. Hirano A, Hirano M, Dembitzer H M. Pathological variations and extent of the disease process in amyotrophic lateral sclerosis. In: Hudson A J, ed. Amyotrophic Lateral Sclerosis: Concepts in Pathogenesis and Etiology. Toronto, Untario: University of Toronto Press, 1990: 166-192.
74. + exchanger in cultured rat astrocytes. J Neurochem 1995; 64: 1536-1540.
75. Blaustein M P. Calcium transport and buffering in neurons. Trends Neurosci 1988; 11: 438-443.
76. Tsao C S. Equilibrium constant for calcium ion and ascorbate ion. Experientia 1984; 40: 168-170.
77. Cheng L, Coihen M, Bhagavan H N. Vitamin C and the elderly: In: Watson R R, ed. CRC Handbook of Nutrition in the Aged. Boca Raton, FL: CRC Press, 1985: 157-185.
78. Brook M, Grimshaw J J. Vitamin C concentration of plasma and leukocytes as related to smoking habit, age, and sex of humans. Am J Clin Nutr 1968; 21: 1254-1258.
79. Oreopoulos D G, Lindeman R D, VanderJagt D J, Tzamaloukas A H, Bhagavan H N, Garry P J. Renal excretion of ascorbic acid: effect of age and sex. J Am Coll Nutr 1993; 12: 537-542.
80. Svensson L, Wu C, Hulthe P, Johannessen K, Engel J A. Effect of ageing on extracellular ascorbate concentration in the rat brain. Brain Research 1993; 609: 36-40.
81. Brin M, Dibble M V, Peel A et al. Some preliminary findings on the nutritional status of the aged in Onondaga County, New York. Am J Clin Nutr 1965; 17: 240-258.
82. Vanderjagt D J, Garry P J, Bhagavan H N. Ascorbate intake and plasma levels in healthy elderly people. Am J Clin Nutr 1987; 46: 290-294.
83. Rosen A D. Amyotrophic lateral sclerosis: clinical features and prognosis. Arch Neurol 1978; 35: 638-642.
84. Muramoto S, Saitoh M. [Prognosis of amyotrophic lateral sclerosis-clinical analysis]. No To Shinkei 1995; 47: 659-664.
85. Munsat T L, Andres P, Taft J. The nature of clinical change in ALS. In: Tsubaki T, Yase, Y, eds. ALS: Recent Advances in Research and Treatment. Proceedings of the International Conference on ALS, Kyoto, Japan 1988: 203-206.
86. Ferris D C, Kume-Kick J, Russo-Menna I, Rice M E. Gender differences in cerebral ascorbate levels and ascorbate loss in ischemia. Neuroreport 1995; 6: 1485-1489.
87. Hagtvet J. Norske Serumaskorbinsyreverdier hos friske 1940-1942 [Serum ascorbic acid values in healthy Norwegians from 1940-1942]. Nordisk Medicin 1945; 28: 2335-2336.
88. Spector R, Lorenzo A V. Ascorbic acid homeostasis in the central nervous system. Am J Physiol 1973; 225: 757-763.
89. Spector R, Lorenzo A V. Specificity of the ascorbic acid transport system of the central nervous system. Am J Physiol 1974; 226: 1468-1473.
90. Rennels M L, Blaumanis O R, Grady P A. Rapid solute transport throughout the brain via paravascular fluid pathways. Adv Neurol 1990; 52: 431-439.
91. Rennels M L, Gregory T F, Blaumanis O R, Fujimoto K, Grady P A. Evidence for a 'paravascular' fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space. Brain Research 1985; 326: 47-63.
92. Lam D K C, Daniels P M. The influx of ascorbate acid into the rat's brain. Q J Exper Physiol 1986; 71: 483-489.
93. Rose R. Transport of ascorbic acid and other water-soluble vitamins. Biochim Biophys Acta 1988; 947: 335-366.
94. Kapeghian J C, Verlangieri A J. The effects of glucose on ascorbic acid uptake in heart endothelial cells: possible pathogenesis of diabetic angiopathies. Life Sciences 1984; 34: 577-584.
95. Stankova L, Riddle M, Larned J et al. Plasma ascorbate concentrations and blood cell dehydroxyascorbate transport in patients with diabetes mellitus. Metabolism 1984; 33: 347-353.
96. Som S, Basu S, Mukherjee D et al. Ascorbic acid metabolism in diabetes mellitus. Metabolism 1981; 30: 572-577.
97. Hubbard R W, Will A D, Peterson G W, Sanchez A, Gillan W W, Tan S A. Elevated plasma glucagon in amyotropic lateral sclerosis. Neurology 1992; 42: 1532-1534.
98. Wilson J X. Ascorbic acid uptake by a high-affinity sodium-dependent mechanism in cultured rat astrocytes. J Neurochem 1989; 53: 1064-1071.
99. Sharma S K, Johnstone R M, Quastel J H. Active transport of ascorbic acid in adrenal cortex and brain cortex. Can J Biochem Physiol 1963; 41: 597-604.
100. Siushansian R, Wilson J X. Ascorbate transport and intracellular concentration in cerebral astrocytes. J Neurochem 1995; 65: 41-48.
101. Padh H, Aleo J J. Activation of serum complement leads to inhibition of ascorbic acid transport. Proc Soc Exper Biol Med 1987; 185: 153-157.
102. Padh H, Aleo J J. Ascorbic acid transport by 3T6 fibroblasts. Regulation by and purification of human serum complement factor. J Biol Chem 1989; 264: 6065-6069.
103. Donnenfeld H, Kascsak R J, Bartfeld H. Deposits of IgG and C3 in the spinal cord and motor cortex of ALS patients. J Neuroimmunol 1984; 6: 51-57.
104. Gasque P, Julen N, Ischenko A M et al. Expression of complement components of the alternative pathway by glioma cell lines. J Immunol 1992; 149: 1381-1387.
105. Kawamata T, Akiyama H, Yamada T, McGeer P L. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol 1992; 140: 691-707.
106. Annunziata P, Volpi N. High levels of C3c in the cerebrospinal fluid from amyotrophic lateral sclerosis patients. Acta Neurologica Scandinavia 1985; 72: 61-64.
107. Takase S. CSF finding of patients win ALS. Rinsho Shinkeigaku (Clinical Neurology) 1984; 24: 1257-1261.
108. Amaducci L, Falcini M, Lippi A. Humoral and cellular immunologic repertoire in Alzheimer's disease. Ann NY Acad Sci 1992; 663: 349-356.
109. Troost D, van den Oord J J, de Jong J M, Swaab D F. Lymphocytic infiltration in the spinal cord of patients with amyotrophic lateral sclerosis. Clin Neuropathol 1989; 8: 289-294.
110. Troost D, Claessen N, van den Oord J J, Swaab D F, de Jong J M. Neuronophagia in the motor cortex in amyotrophic lateral sclerosis. Neuropathol App Neurobiol 1993; 19: 90-97.
111. Smith R G, Engelhardt J I, Tajti J, Appel S H. Experimental immune-mediated motor neuron diseases: models for human ALS. Brain Res Bull 1993; 30: 373-380.
112. Landis R C, Friedman M L, Fisher R I, Ellis T M. Induction of human monocyte IL-1 mRNA and secretion during anti-CD3 mitogenesis requires two distinct T cell-derived signals. J Immunol 1991; 146: 128-135.
113. Lukacs N W, Kunkel S L, Burdick M D, Lincoln P M, Strieter R M. Interleukin-1 receptor antagonist blocks chemokine production in the mixed lymphocyte reaction. Blood 1993; 82: 3668-3674.
114. Shingu M, Nonaka S, Nishimukai H, Nobunaga M, Kitamura H, Tomo-Oka K. Activation of complement in normal serum by hydrogen peroxide and hydrogen peroxide-related oxygen radicals produced by activated neutrophils. Clin Exper Immunol 1992; 90: 72-78.
115. Jackson I, Adelman L S, Munsat T L, Forte S, Lechan R M. Amyotrophic lateral sclerosis: thyrotropin-releasing hormone and histidyl proline diketopiperazine in the spinal cord and cerebrospinal fluid. Neurology 1986; 36: 1218-1223.
116. Bertel O, Malessa S, Sluga E, Hornykiewicz O. Amyotrophic lateral sclerosis: changes of noradrenergic and serotonergic transmitter systems in the spinal cord. Brain Research 1991; 566: 54-60.
117. Sofic E, Riederer P, Gsell W, Gavranovic M, Schmidtke A, Jellinger K. Biogenic amines and metabolites in spinal cord of patients with Parkinson's disease and amyotropic lateral sclerosis. J Neural Trans (Parkinson's Disease Section) 1991; 3: 133-142.
118. Ekblom J, Aquilonius S M, Jossan S S. Differential increases in catecholamine metabolizing enzymes in amyotropic lateral sclerosis. Exper Neurol 1993; 123: 289-294.
119. Ekblom J, Jossan S S, Bergstrom M, Oreland L, Walum E, Aquilonius S-M. Monoamine oxidase-B in astrocytes. Glia 1993; 8: 122-132.
120. Aquilonius S M, Jossan S S, Ekblom J G, Askmark H, Gillberg P G. Increased binding of 3H-L-deprenyl in spinal cords from patients with amyotrophic lateral sclerosis as demonstrated by autoradiography. J Neural Trans (General Section) 1992; 89: 111-122.
121. den Hartog Jager W A. Experimental amyotrophic lateral sclerosis in the guinea-pig. J Neurol Sci 1985; 67: 133-142.
122. Sillevis Smitt P A, de Jong J M, Troost D, Kuipers M A. Muscular changes in the guinea pig caused by chronic ascorbic acid deficiency. J Neurol Sci 1991; 102: 4-10.
123. Shils M E. The need for adequate control groups in nutrition studies. J Neurol Sci 1991; 102: 1-3.
124. Woitowitz H J, Rosler J. Amyotrophic lateral sclerosis after long-term exposure to lead. D Med Wochenschrift 1995; 120: 424.
125. Sillevis-Smitt P A, Mulder T P, Verspaget H W, Blaauwgeers H G, Troost D, Vianney de Jong J M B. Metallothionein in amyotrophic lateral sclerosis. Biological Signals 1994; 3: 193-197.
126. Kurlander H M, Patten B M. Metals in patients dying of motor neuron disease. Ann Neurol 1979; 6: 21-24.
127. Patten B M. ALS associated with aluminum intoxication. In: Tsubaki T, Yase Y, eds. Amyotrophic Lateral Sclerosis: Recent Advances in Research and Treatment. Amsterdam: Elsevier Science Publishers, 1988.
128. Tamai K T, Gralla E B, Ellerby L M, Valentine J S, Thiele D J. Yeast and mammalian metallothioneins functionally substitute for yeast copper-zinc superoxide dismutase. Proc Natl Acad Sci USA 1993; 90: 8013-8017.
129. Garruto R M, Shankar S K, Yanagihara R, Salazar A M, Amyx H L, Gajdusek D C. Low-calcium, high aluminum diet-induced motor neuron pathology in cynomolgus monkeys. Acta Neuropathol 1989; 78: 210-219.
130. Serra M A, Barassi V, Canavese C, Sabbioni E. Aluminum effect on the activity of superoxide dismutase and of other antioxygenic enzymes in vitro. Biol Trace Elem Res 1991; 31: 79-96.
131. Kong S, Liochev S, Fridovich I. Aluminum (III) facilitates the oxidation of NADH by the superoxide anion. Free Rad Biol Med 1992; 13: 79-81.
132. Abreo K, Glass J. Cellular biochemical, and molecular mechanisms of aluminum toxicity. Nephrology, Dialysis, Transplantation Supplement 1993; 1: 5-11.
133. Verlangieri A J, Fay M J, Bannon A W. Comparison of the anti-scorbutic activity of L-ascorbic acid and ester C in the non-ascorbate synthesizing osteogenic disorder Shionogi (ODS) rat. Life Sciences 1991; 48: 2275-2281.
134. Reiner A, Medina L, Figueredo-Cardenas G, Anfinson S. Brainstem motoneuron pool areas that are selectively resistant in amyotrophic lateral sclerosis are preferentially enriched in parvalbumin: evidence from monkey brainstem for a calcium-mediated mechanisn in sporadic ALS. Exper Neurol 1995; 131: 239-250.
135. Elliott J L, Snider W D. Differential gene expression in ALS-sensitive and ALS-resistant motor neurons. Neurology 1995; (Suppl4): 509P.
136. Okamoto K, Hirai S, Nakagawa T, Sakurai A, Morita M, Yanagisawa T. Parvalbumin-positive small myelinated fiber bundles in anterior marginal areas in the human cervical cord. Neurosci Lett 1995; 185: 79-82.
137. Ince P, Stout N, Shaw P et al. Parvalbumin and calbindin D-28k in the human motor system and in motor neuron disease. Neuropathol App Neurobiol 1993; 19: 291-299.
138. Kiehn O. Plateau potentials and active integration in the 'final common pathway' for motor behaviour. Trends Neurosci 1991; 14: 68-73.
139. Schwindt P C, Crill W E. Membrane properties of cat spinal motoneurons. In: Davidoff R A, ed. Handbook of the Spinal Cord. New York: Marcel Dekker, 1984.
140. Eken T, Kiehn O. Bistable firing properties of soleus motor units in freely moving rats. Acta Physiol Scand 1989; 136: 383-394.
141. Eken K, Hultbom H, Kiehn O. Possible functions of transmitter-controlled potentials in α-motorneurones. Prog Brain Res 1989; 80: 257-267.
142. Schwindt P, Crill W. Role of persistent inward current in motorneuron bursting during spinal seizures. J Neurophysiol 1980; 43: 1296-1318.
143. Baldissera F, Cavallari P, Dworzak F. Motor neuron 'bistability:' a pathogenic mechanism for cramps and myokymia. Brain 1994; 117: 929-939.
144. Kiehn O, Rostrup E, Moller M. Monoaminergic systems in the brainstem and spinal cord of the turtle Pseudemys scripta elegans as revealed by antibodies against serotonin and tyrosine hydroxylase. J Comp Neurol 1992; 325: 527-547.
145. Pearson J C, Alvarez D E, Dewey, Harrington D, Fyffe R E W. Serotonergic innervation of motoneurons in the cat's lumbar spinal cord. Soc Neurosci Abstr 1993; 19: 983, 23rd Meeting, Washington, DC.
146. Sciamanna M A, Lee C P. Ischemia/reperfusion-induced injury of forebrain mitochondria and protection by ascorbate. Arch Biochem Biophys 1993; 305: 215-224.
147. Bayliss D A, Viana F, Berger A J. Effects of thyrotropin-releasing hormone on rat motoneurons are mediated by G proteins. Brain Research 1994; 668: 220-229.
148. Cook D L, Satin L S, Hopkins W F. Pancreatic cells are bursting, but how? Trends Neurol Sci 1991; 14: 411-414.
149. Turrigiano G, Abbott L F, Marder E. Activity-dependent changes in the intrinsic properties of cultured neurons. Science 1994; 264: 974-977.
150. Appel S H, Smith R G, Alexianu M et al. Neurodegenerative disease: autoimmunity involving calcium channels. Ann NY Acad Sci 1994; 747: 183-194.
151. Fernandes R S, Cotter T G. Apoptosis or necrosis: intracellular levels of glutathione influence mode of cell death. Biochem Pharmacol 1994; 48: 675-685.
152. Sarafian T A, Bredesen D E. Invited commentary, is apoptosis mediated by reactive oxygen species.? Free Radical Research 1994; 21 (1): 1-8.
153. Ratan R R, Murphy T H, Baraban J M. Oxidative stress induces apoptosis in embryonic cortical neurons. J Neurochem 1994; 62: 376-379.
154. Buttke T M, Sandstrom P A. Oxidative stress as a mediator of apoptosis. Immunology Today 1994; 15: 710.
155. Corcoran G B, Fix L, Jones D P et al. Apoptosis: molecular control point in toxicity. Toxicol Appl Pharmacol 1994; 128: 169-181.
156. Duvall E, Wyllie A H. Death and the cell. Immunology Today 1986; 7: 115-119.
157. Nosseri C, Coppola S, Ghibelli L. Possible involvement of poly(ADP-ribosyl) polymerase in triggering stress-induced apoptosis. Exp Cell Res 1994; 212: 367-373.
158. Choi D W. Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci 1995; 18: 58-60.
159. Appel S H, Engelhardt J I, García J, Stefani E. Immunoglobulins from animal models of amyotrophic lateral sclerosis patients passively transfer physiological abnormalities to the neuromuscular junction. Proc Natl Acad Sci 1991; 88: 647-651.
160. Llinas R, Sugimori M, Cherksey B D et al. IgG from amyotrophic lateral sclerosis patients increases current through P-type calcium channels in mammalian cerebellar Purkinje cells and in isolated channel protein in lipid bilayer. Proc Natl Acad Sci 1993; 90: 11743-11747.
161. Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979; 59: 527-603.
162. Sohal R S, Brunk U T. Mitochondrial production of prooxidants and cellular senescence. Mutat Res 1992; 275: 295-304.
163. Ku H-H, Brunk U T, Sohal R S. Relationship between mitochondrial superoxide and hydrogen peroxide production and longevity of mammalian species. Free Rad Biol Med 1993; 15: 621-627.
164. Chandrasekaran K, Stoll J, Brady D R, Rapoport S I. Localization of cytochrome oxidase (COX) activity and COXmRNA in the hippocampus and entorhinal cortex of the monkey brain: correlation with specific neuronal pathways. Brain Research 1992; 579: 333-336.
165. Parker W D, Parks J, Filley C M, Kleinschmidt-DeMasters B K. Electron transport chain defects in Alzheimer's disease brain. Neurology 1994; 44: 1090-1096.
166. Tsukagoshi H, Yin Q, Yamada M, Wada Y, Furukawa T, Yanagisawa N. Morphometric study on the spinal cord of ALS: quantification of the number and size of anterior horn cells of the cervical cord. In: Tsubaki T, Yase Y, eds. ALS: Recent Advances in Research and Treatment. Proc Int Conf on ALS, Kyoto, Japan 1988; 193-198.
167. DeLuca C J, Erim Z. Common drive of motor units in regulation of muscle force. Trends Neurosci 1994; 17: 299-305.
168. Brooks B R. The role of axonal transport in neurodegenerative disease spread: a metaanalysis of experimental and clinical poliomyelitis compares with amyotrophic lateral sclerosis. Can J Neurol Sci 1991; 18 (3 Suppl): 435-438.
169. Rowland L P, Sherman W H, Latov N et al. Amyotrophic lateral sclerosis and lymphoma: bone marrow examination and other diagnostic tests. Neurology 1992; 42: 1101-1102.
170. Spector R. Vitamin homeostasis in the central nervous system. N Engl J Med 1977; 296: 1393-1398.
171. Bannon A W, Verlangieri A J, Wilson, Kallman M J. The effects of various levels of ascorbic acid on the response of the ODS rat to trimethyltin. Neurotoxicology 1993; 14: 437-444.